Subscribe Now Subscribe Today
Abstract
Fulltext PDF
References
Research Article
 

Non-albicans Candida Species in Cancer Patients



E. Dorko , M. Kmetova , E. Pilip inec , F. Dorko , I.Braokova , A. Marossy and I. Skardova
 
ABSTRACT

The authors analyze incidence of non-albicans Candida species and non-Candida species isolated from cancer patients. The results of examination shown that presence of 9 non-albicans Candida spp. and non-Candida spp.: C.parapsilosis (n=20), C.tropicalis (n=9), C.krusei (n=4), Cr.neoformans (n=2), C.claussenii, C.intermedia, C.mogii, C.pulcherrima and C.zeylanoides (n=1 each). Classifying the sample according to the patient`s diagnosis, the yeasts were most frequently isolated from patients with leukemia (n=14), with non-specified cerebral tumor (n=6), Hodgkin`s disease (n=3), squamous cell carcinoma of oral cavity (n=3), myeloma (n=2), and other neoplastic diseases (lymphoma, non-specified tumor of larynx, nasal cavity and middle ear, colon tumor, non-Hodgkin´s lymphomas, breast cancer). Regarding the localization of samples in which the above yeasts were detected, most frequently the positive samples were found in swabs taken from oropharyngeal region (n=11) and blood (n=10).

Services
Related Articles in ASCI
Similar Articles in this Journal
Search in Google Scholar
View Citation
Report Citation

 
  How to cite this article:

E. Dorko , M. Kmetova , E. Pilip inec , F. Dorko , I.Braokova , A. Marossy and I. Skardova , 2001. Non-albicans Candida Species in Cancer Patients . Journal of Medical Sciences, 1: 11-15.

DOI: 10.3923/jms.2001.11.15

URL: https://scialert.net/abstract/?doi=jms.2001.11.15

REFERENCES
Abi-Said, D., E. Anaissie, O. Uzun, I. Raad, H. Pinzcowski and S. Vartivarian, 1997. The epidemiology of hematogenous candidiasis caused by different Candida species. Clin. Infect. Dis., 24: 1122-1128.
CrossRef  |  Direct Link  |  

Anaissie, E.J., J.H. Rex, O. Uzun and S. Vartivarian, 1998. Predictors of adverse outcome in cancer patients with Candidemia. Am. J. Med., 104: 238-245.
CrossRef  |  Direct Link  |  

Antrum, J., 1996. Meeting the challenge of systemic fungal infections in cancer: Nursing implications. Eur. J. Haematol., 56: 7-11.
CrossRef  |  Direct Link  |  

Berrouane, Y.F., R.J. Hollis and M.A. Pfaller, 1996. Strain variation among and antifungal susceptibilities of isolates of Candida krusei. J. Clin. Microbiol., 34: 1856-1858.
Direct Link  |  

Branchini, M.L., M.A. Pfaller, J. Rhine-Chalberg, T. Frempong and H.D. Isenberg, 1994. Genotypic variation and slime production among blood and catheter isolates of Candida parapsilosis. J. Clin. Microbiol., 32: 452-456.
Direct Link  |  

De Pauw, B.E., 1997. Practical modalities for prevention of fungal infections in cancer patients. Eur. J. Clin. Microbiol. Infect. Dis., 16: 32-41.
CrossRef  |  Direct Link  |  

Dorko, E., M. Kmetova, J. Durovicova and F. Dorko, 1999. CHROMagar Candida-a new means for the identification of yeasts. Remedia, 3: 74-76, (In Czech).
Direct Link  |  

Herbrecht, R., 1996. The changing epidemiology of fungal infections: Are the lipid-based forms of amphotericin B an advance? Eur. J. Haematol., 56: 12-17.
CrossRef  |  Direct Link  |  

Kalin, M. and B. Petrini, 1996. Clinical and laboratory diagnosis of invasive candida infection in neutropenic patients. Med. Oncol., 13: 223-231.
CrossRef  |  Direct Link  |  

Korfel, A., H.D. Menssen, S. Schwartz and E. Thiel, 1998. Cryptococcosis in Hodgkin's disease: Description of two cases and review of the literature. Ann. Hematol., 76: 283-286.
CrossRef  |  Direct Link  |  

Kralovicova, K., S. Spanik, E. Oravcova, M. Mrazova and E. Morova et al., 1997. Fungemia in cancer patients undergoing chemotherapy versus surgery: Risk factors, etiology and outcome. Scand. J. Infect. Dis., 29: 301-304.
CrossRef  |  Direct Link  |  

Krcmery, Jr.V., 1996. Emerging fungal infections in cancer patients. J. Hospt. Infect., 33: 109-117.
CrossRef  |  Direct Link  |  

Krcmery, Jr.V., E. Oravcova, S. Spanik, M. Mrazova-Studena and J. Trupl et al., 1998. Nosocomial breakthrough fungaemia during antifungal prophylaxis or empirical antifungal therapy in 41 cancer patients receiving antineoplastic chemotherapy: Analysis of aetiology risk factors and outcome. J. Antimicrob. Chemother., 41: 373-380.
CrossRef  |  Direct Link  |  

Krcmery, Jr.V., S. Spanik, S. Grausova, J. Trupl and I. Krupova et al., 1998. Candida parapsilosis fungemia in cancer patients-incidence, risk factors and outcome. Neoplasma, 45: 336-342.
PubMed  |  Direct Link  |  

Kunova, A., J. Trupl, S. Spanik, L. Drgona and J. Sufliarsky et al., 1995. Candida glabrata, Candida krusei, non-albicans Candida spp. and other fungal organisms in a sixty-bed national cancer center in 1989-1993: No association with the use of fluconazole. Chemotherapy, 41: 39-44.
CrossRef  |  Direct Link  |  

Nikawa, H., H. Nishimura, T. Hamada and S. Sadamori, 1997. Quantification of thigmotropism (contact sensing) of Candida albicans and Candida tropicalis. Mycopathologia, 138: 13-19.
CrossRef  |  Direct Link  |  

Nucci, M., M.I. Silveira, N. Spector, F. Silveira and E. Velasco et al., 1998. Fungemia in cancer patients in Brazil: Predominance of non-albicans species. Mycopathologia, 141: 65-68.
CrossRef  |  Direct Link  |  

Rodero, L., M. Boutureira, H. Demkura, A. Burkett and C. Fernandez et al., 1997. Yeast infections: Causative agents and their antifungal resistance in hospitalized pediatric patients and HIV-positive adults. Rev. Argent. Microbiol., 29: 7-15, (In Spanish).
PubMed  |  Direct Link  |  

Spanik, S., T. Kollar, J. Gyarfas, A. Kunova and V.Jr. Krcmery, 1995. Successful treatment of catheter-associated fungemia due to Candida krusei and Trichosporon beigelii in a leukemic patient receiving prophylactic itraconazole. Eur. J. Clin. Microbiol. Infect. Dis., 14: 148-149.
PubMed  |  Direct Link  |  

Venkateswarlu, K., D.W. Denning, N.J. Manning and S.L. Kelly, 1996. Reduced accumulation of drug in Candida krusei accounts for itraconazole resistance. Antimicrob. Agents Chemother., 40: 2443-2446.
Direct Link  |  

Wingard, J.R., 1995. Importance of Candida species other than C. albicans as pathogens in oncology patients. Clin. Infect. Dis., 20: 115-125.
CrossRef  |  Direct Link  |  

©  2019 Science Alert. All Rights Reserved
Fulltext PDF References Abstract